Caprion, Vertex Pharma, UCD Conway Institute, Nonlinear Dynamics, BG Medicine, Mitsubishi Pharma, BD Biosciences, Dynomics, PerkinElmer, NCGC, ABI/MDS Sciex, Deltadot

Mar 30, 2006

Premium

Caprion Will Use CellCarta to Help Vertex Pharma Discover Biomarkers

Vertex Pharmaceuticals will rely on data from Caprion Pharmaceuticals' CellCarta proteomics platform as part of a biomarker-discovery collaboration, Caprion said this week.

As part of the deal, Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and pre-clinical studies conducted by Vertex.

Caprion's platform profiles proteins and provides protein expression and identification in tissues and blood plasma.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Main menu